Work

Abstract 338: Discovery of novel pan-PI3K and mTOR dual inhibitors as first-in-class antibody-drug conjugate payloads.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-338

Authors: Qi Liu, Lan Pham, Chin Pan, Jin Wang, Kamaldeep S. Dhami, Yingchun Li, Jeffrey Serrill, Ravi Kasiappan, Felix DeAnda, Screenivas Punna, Karl Haelsig, Apeksha Villath, Ketaki Gadkari, Geunbae Rha, Deanna Haasch, Albert Lai, James W. Purcell, Xueqing Wang

Institution: AbbVie (United States)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148833645

Cites:

Cited by:

Related to: